Cargando…
Sequestration of Inflammation in Parkinson’s Disease via Stem Cell Therapy
Parkinson’s disease is the second most common neurodegenerative disease. Insidious and progressive, this disorder is secondary to the gradual loss of dopaminergic signaling and worsening neuroinflammation, affecting patients’ motor capabilities. Gold standard treatment includes exogenous dopamine th...
Autores principales: | Gordon, Jonah, Lockard, Gavin, Monsour, Molly, Alayli, Adam, Choudhary, Hassan, Borlongan, Cesario V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456021/ https://www.ncbi.nlm.nih.gov/pubmed/36077534 http://dx.doi.org/10.3390/ijms231710138 |
Ejemplares similares
-
The Role of Concomitant Nrf2 Targeting and Stem Cell Therapy in Cerebrovascular Disease
por: Gordon, Jonah, et al.
Publicado: (2022) -
Mitochondria in Cell-Based Therapy for Stroke
por: Monsour, Molly, et al.
Publicado: (2023) -
Stem Cells: Recent Developments Redefining Epilepsy
Therapy
por: Alayli, Adam, et al.
Publicado: (2023) -
Stem Cells Attenuate the Inflammation Crosstalk Between Ischemic Stroke and Multiple Sclerosis: A Review
por: Monsour, Molly, et al.
Publicado: (2023) -
Probing Interleukin-6 in Stroke Pathology and Neural Stem Cell Transplantation
por: Lockard, Gavin Miles, et al.
Publicado: (2022)